Similarly, in the mouse model of glaucoma, the expression levels of RIP1 and RIP3 were significantly increased at 1, 3, and 5 days after NMDA injection compared with the saline-treated group (Fig. 4b). The gene discussed is RIPK1; the disease is glaucoma.